C

Supernus, Inc. SUPN

$28.61 $0.260.92% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$28.15$29.51
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

SUPN Rating

Reward
Risk

SUPN Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

SUPN Company Overview

Indivior PLC is a global specialty pharmaceutical company focused primarily on developing, manufacturing, and commercializing treatments for substance use disorders and serious mental illnesses. The company operates within the biopharmaceutical and addiction treatment industries, with a strategic emphasis on opioid use disorder (OUD) therapies, schizophrenia treatments, and related central nervous system (CNS) conditions. Its principal revenue drivers have historically included SUBLOCADE, an extended-release injectable buprenorphine treatment for OUD, and legacy products such as SUBOXONE Film. The company serves healthcare providers, treatment centers, government agencies, managed care organizations, and patients across multiple international markets.

Indivior originated as a business unit within Reckitt Benckiser before becoming an independent publicly traded company in 2014 through a demerger. Since its separation, the company has evolved from a business heavily dependent on opioid dependence therapies toward a broader addiction science and neuropsychiatry platform. Its positioning is supported by established clinical expertise in addiction medicine, specialized commercialization capabilities in behavioral health, and a portfolio centered on long-acting injectable therapies designed to improve treatment adherence and patient outcomes.

Data compiled by narrative technology. May contain errors.
Sector

SUPN Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

SUPN Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

SUPN Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

SUPN Price History

Loading...
52-Week Range16% of range
Current
$28.61
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

SUPN Valuation

Market Cap
Market Cap Rank
#3,211
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

SUPN Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

SUPN Corporate Info

Phone Number
301 838 2500
Address
9715 Key West Avenue
Rockville, MD 20850
Country
Year Founded

SUPN Filings

Filing Date
Thursday, October 29, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 22 and 26 (est)

SUPN Headlines